51098AST
Astec® Cellulose DMP Chiral (5 μm) HPLC Column
L × I.D. 15 cm × 4.6 mm, HPLC Column
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
Recommended Products
product name
Astec® Cellulose DMP Chiral HPLC Column, 5 μm particle size, L × I.D. 15 cm × 4.6 mm
material
stainless steel column
Agency
suitable for USP L40
product line
Astec®
packaging
pkg of 1 ea
manufacturer/tradename
Astec®
parameter
0-40 °C temperature
50 bar pressure (725 psi)
technique(s)
HPLC: suitable
L × I.D.
15 cm × 4.6 mm
matrix
fully porous particle
silica gel high purity, spherical
silica gel particle platform
matrix active group
cellulose, DMPC- phase
particle size
5 μm
pore size
100 Å pore size
operating pH
3.5-6.8
separation technique
chiral
Looking for similar products? Visit Product Comparison Guide
General description
Astec® Cellulose DMP HPLC columns separate a wide range of chiral compounds under normal phase, polar organic, and SFC conditions. They exhibit high efficiency, high loading capacity, and excellent column lifetime. With performance comparable to other DMPC-derivatized cellulose CSPs, but at substantially lower price, Astec® Cellulose DMP is a must-have for every chiral column HPLC or SFC screening protocol. Astec® Cellulose DMP is complementary to the other Astec® CSPs, including CHIROBIOTIC®, CYCLOBOND and the P-CAP™ product lines.
Description: Spherical, porous silica coated with DMPC (dimethylphenyl carbamate)-derivatized cellulose
Particle diameter: 5 μm
Field of Use: Small molecule enantiomer separations in normal phase, polar organic, and SFC modes
Description: Spherical, porous silica coated with DMPC (dimethylphenyl carbamate)-derivatized cellulose
Particle diameter: 5 μm
Field of Use: Small molecule enantiomer separations in normal phase, polar organic, and SFC modes
Legal Information
Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC
P-CAP is a trademark of Sigma-Aldrich Co. LLC
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Katrijn De Klerck et al.
Journal of pharmaceutical and biomedical analysis, 69, 77-92 (2012-03-01)
Chirality has a significant impact on drug discovery and development processes in the pharmaceutical industry. As the number of enantiopure drugs launched onto the market is yearly increasing, the need for fast and performant enantioseparation methods with minimal costs is
Katrijn De Klerck et al.
Journal of chromatography. A, 1328, 85-97 (2014-01-21)
Since their introduction on the market the applicability of immobilized polysaccharide-based chiral stationary phases in high-performance liquid chromatography has been thoroughly investigated. These immobilized phases have the benefit to be applicable with a wide range of modifiers, potentially extending the
Chromatograms
application for HPLCapplication for HPLCapplication for HPLCapplication for HPLCShow MoreOur team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service